GEG-tech is a French biotechnology company developing high performance vectorization systems based on lentiviruses. Its expertise relies on a 15-year experience R&D team. GEG-tech constantly innovates to improve lentiviral vector features, capabilities and safety.
Histalim is a service provider company in histology, immunohistochemistry (IHC), in situ hybridization (ISH), and image analysis. Its laboratory located in Montpellier was founded in 2005 while its sale offices in Berlin were opened in 2014. This positioning shows its willingness to meet the increasing demand to design, develop, and validate protocols based on standard and/or innovative techniques.
PEP Therapy is a biotech company developing targeted therapies for the treatment of severe diseases, with an initial focus on cancer.
NeuroSys is both a CRO and a drug discovery company focused on neurodegenerative diseases.
SMALTIS is a biotech company specialized in bacteriology and molecular biology.
Innate Pharma is a biopharma company developing therapeutic antibodies for the treatment of cancer and inflammatory diseases.
Oncodesign is a biotech company offering preclinical evaluation of anticancer therapies (Pharmimage, PREDICT, Chi-Mice, Nanocyclix, etc…).
Invectys is a biotech company proposing immunotherapeutic cancer vaccine targeting the human telomerase.
Poxel is a biopharma company developing innovative drugs for metabolic diseases, in particular Type 2 diabetes.
Eligo Bioscience is a biotech company developing a new generation of antibiotics, called “eligobiotics”.
